452 related articles for article (PubMed ID: 29335749)
41. Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion.
Velychko S; Kang K; Kim SM; Kwak TH; Kim KP; Park C; Hong K; Chung C; Hyun JK; MacCarthy CM; Wu G; Schöler HR; Han DW
Cell Rep; 2019 Apr; 27(1):30-39.e4. PubMed ID: 30943410
[TBL] [Abstract][Full Text] [Related]
42. Cnidarian hair cell development illuminates an ancient role for the class IV POU transcription factor in defining mechanoreceptor identity.
Ozment E; Tamvacakis AN; Zhou J; Rosiles-Loeza PY; Escobar-Hernandez EE; Fernandez-Valverde SL; Nakanishi N
Elife; 2021 Dec; 10():. PubMed ID: 34939935
[TBL] [Abstract][Full Text] [Related]
43. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities.
Ghislain J; Charnay P
EMBO Rep; 2006 Jan; 7(1):52-8. PubMed ID: 16311519
[TBL] [Abstract][Full Text] [Related]
44. Characterization of two POU transcription factor family members from the urochordate Oikopleura dioica.
Cupit PM; Lennard ML; Hikima J; Warr GW; Cunningham C
Gene; 2006 Nov; 383():1-11. PubMed ID: 16989962
[TBL] [Abstract][Full Text] [Related]
45. Reprogramming cell fate with a genome-scale library of artificial transcription factors.
Eguchi A; Wleklinski MJ; Spurgat MC; Heiderscheit EA; Kropornicka AS; Vu CK; Bhimsaria D; Swanson SA; Stewart R; Ramanathan P; Kamp TJ; Slukvin I; Thomson JA; Dutton JR; Ansari AZ
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8257-E8266. PubMed ID: 27930301
[TBL] [Abstract][Full Text] [Related]
46. Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells.
Catena R; Tiveron C; Ronchi A; Porta S; Ferri A; Tatangelo L; Cavallaro M; Favaro R; Ottolenghi S; Reinbold R; Schöler H; Nicolis SK
J Biol Chem; 2004 Oct; 279(40):41846-57. PubMed ID: 15262984
[TBL] [Abstract][Full Text] [Related]
47. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins.
Verrijzer CP; van Oosterhout JA; van der Vliet PC
Mol Cell Biol; 1992 Feb; 12(2):542-51. PubMed ID: 1346336
[TBL] [Abstract][Full Text] [Related]
48. Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming.
Stadhouders R; Vidal E; Serra F; Di Stefano B; Le Dily F; Quilez J; Gomez A; Collombet S; Berenguer C; Cuartero Y; Hecht J; Filion GJ; Beato M; Marti-Renom MA; Graf T
Nat Genet; 2018 Feb; 50(2):238-249. PubMed ID: 29335546
[TBL] [Abstract][Full Text] [Related]
49. TRANSDIRE: data-driven direct reprogramming by a pioneer factor-guided trans-omics approach.
Eguchi R; Hamano M; Iwata M; Nakamura T; Oki S; Yamanishi Y
Bioinformatics; 2022 May; 38(10):2839-2846. PubMed ID: 35561200
[TBL] [Abstract][Full Text] [Related]
50. POU domain transcription factors from different subclasses stimulate adenovirus DNA replication.
Verrijzer CP; Strating M; Mul YM; van der Vliet PC
Nucleic Acids Res; 1992 Dec; 20(23):6369-75. PubMed ID: 1475198
[TBL] [Abstract][Full Text] [Related]
51. Regenerative medicine: Bespoke cells for the human brain.
Sendtner M
Nature; 2011 Aug; 476(7359):158-9. PubMed ID: 21833079
[No Abstract] [Full Text] [Related]
52. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
Babb R; Cleary MA; Herr W
Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
[TBL] [Abstract][Full Text] [Related]
53. The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc.
Mittal V; Cleary MA; Herr W; Hernandez N
Mol Cell Biol; 1996 May; 16(5):1955-65. PubMed ID: 8628262
[TBL] [Abstract][Full Text] [Related]
54. The POU domain is a bipartite DNA-binding structure.
Sturm RA; Herr W
Nature; 1988 Dec; 336(6199):601-4. PubMed ID: 2904656
[TBL] [Abstract][Full Text] [Related]
55. Identification of amino acid residues in the Caenorhabditis elegans POU protein UNC-86 that mediate UNC-86-MEC-3-DNA ternary complex formation.
Röckelein I; Röhrig S; Donhauser R; Eimer S; Baumeister R
Mol Cell Biol; 2000 Jul; 20(13):4806-13. PubMed ID: 10848606
[TBL] [Abstract][Full Text] [Related]
56. The interplay of chromatin and transcription factors during cell fate transitions in development and reprogramming.
Peñalosa-Ruiz G; Bright AR; Mulder KW; Veenstra GJC
Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194407. PubMed ID: 31356991
[TBL] [Abstract][Full Text] [Related]
57. The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-1/Oct6/SCIP.
Sock E; Enderich J; Wegner M
Mol Cell Biol; 1999 Apr; 19(4):2455-64. PubMed ID: 10082511
[TBL] [Abstract][Full Text] [Related]
58. Identification of novel DNA binding sites recognized by the transcription factor mPOU (POU6F1).
Wey E; Schäfer BW
Biochem Biophys Res Commun; 1996 Mar; 220(2):274-9. PubMed ID: 8645295
[TBL] [Abstract][Full Text] [Related]
59. cis-regulatory analysis of the Drosophila pdm locus reveals a diversity of neural enhancers.
Ross J; Kuzin A; Brody T; Odenwald WF
BMC Genomics; 2015 Sep; 16(1):700. PubMed ID: 26377945
[TBL] [Abstract][Full Text] [Related]
60. Brain 4: a novel mammalian POU domain transcription factor exhibiting restricted brain-specific expression.
Mathis JM; Simmons DM; He X; Swanson LW; Rosenfeld MG
EMBO J; 1992 Jul; 11(7):2551-61. PubMed ID: 1628619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
